IRON
Disc Medicine, Inc.
Key Financials
Net Income
$-212184000
↓ 94.0%
Operating Income
$-236022000
↓ 81.9%
EPS (Diluted)
$-6.01
↓ 51.8%
Total Assets
$806.9M
↑ 62.4%
Shareholders' Equity
$739.8M
↑ 66.8%
Total Liabilities
$67.1M
↑ 26.1%
Cash & Equivalents
$91.1M
↓ 52.6%
Long-term Debt
$29.2M
↑ 3.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/14/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 144 | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 4 | 7/14/2026 | View on SEC |
| 144 | 7/13/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
| 144 | 7/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IRON |
| Company Name | Disc Medicine, Inc. |
| CIK | 1816736 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (617) 674-9274 |